-
Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.
Rümke, L. W., Davies, M. A., Vestjens, S. M. T., van der Putten, B. C. L., Bril-Keijzers, W. C. M., van Houten, M. A., Rots, N. Y., Wijmenga-Monsuur, A. J., van der Ende, A., de Gier, B., Vlaminckx, B. J. M. & van Sorge, N. M., 28 Aug 2024, (E-pub ahead of print) In: Journal of clinical microbiology. p. e0076624Research output: Contribution to journal › Article › Academic › peer-review
-
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, 6 May 2023, In: The Lancet. 401, 10387, p. 1499-1507 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
the REMAP-CAP Investigators, 2020, In: JAMA. 324, 13, p. 1317-1329 13 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
